首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   8853篇
  免费   706篇
  国内免费   108篇
耳鼻咽喉   92篇
儿科学   114篇
妇产科学   314篇
基础医学   593篇
口腔科学   225篇
临床医学   1092篇
内科学   1786篇
皮肤病学   111篇
神经病学   225篇
特种医学   344篇
外国民族医学   1篇
外科学   1932篇
综合类   698篇
预防医学   1299篇
眼科学   153篇
药学   492篇
中国医学   53篇
肿瘤学   143篇
  2023年   176篇
  2022年   261篇
  2021年   474篇
  2020年   531篇
  2019年   482篇
  2018年   479篇
  2017年   388篇
  2016年   356篇
  2015年   351篇
  2014年   782篇
  2013年   731篇
  2012年   447篇
  2011年   540篇
  2010年   453篇
  2009年   406篇
  2008年   373篇
  2007年   342篇
  2006年   305篇
  2005年   251篇
  2004年   263篇
  2003年   203篇
  2002年   155篇
  2001年   107篇
  2000年   112篇
  1999年   88篇
  1998年   67篇
  1997年   63篇
  1996年   61篇
  1995年   57篇
  1994年   54篇
  1993年   38篇
  1992年   35篇
  1991年   25篇
  1990年   26篇
  1989年   29篇
  1988年   19篇
  1987年   22篇
  1986年   11篇
  1985年   15篇
  1984年   9篇
  1983年   15篇
  1982年   12篇
  1981年   9篇
  1980年   7篇
  1979年   11篇
  1978年   11篇
  1977年   4篇
  1976年   3篇
  1974年   2篇
  1973年   2篇
排序方式: 共有9667条查询结果,搜索用时 15 毫秒
1.
为了在腰椎退变性疾病保守治疗和融合手术中间地带寻找一种有效的预防与辅助相结合的微创治疗方式,通过对比目前常用的几种腰椎棘突间动态稳定系统的临床疗效观察和优缺点,以及对腰椎棘突间的生理结构、生物力学和相关数据的分析,在充分了解记忆合金材质的基础上,自行设计研究一种记忆合金材料的新型腰椎棘突间动态固定装置,既能重建腰椎的正常生物力学特性,满足人体脊柱的正常活动,又避免对原有结构的破坏,减少术后并发症的发生,同时也可以优化目前的治疗方法。通过研究,腰椎棘突间记忆合金动态稳定装置在理论上效果满意,可以解决现有技术的不足,优于目前的几种腰椎棘突间动态稳定系统。  相似文献   
2.
3.
背景与目的:调强放疗(intensity-modulated radiation therapy,IMRT)中剂量投照失误可导致严重后果,而目前常用的治疗前计划验证方法并不能反映患者真实投照剂量。实现一种评估患者在体剂量执行准确度的方法,能够在分次治疗中及时发现较大剂量错误,避免发生患者投照剂量过高或不足。方法:复旦大学附属肿瘤医院收治的患者首次实施治疗前行锥形束计算机断层成像(cone beam computed tomography,CBCT)扫描,与定位CT图像进行配准保证治疗体位与模拟定位时一致,实时治疗中使用电子射野影像装置(electronic portal imaging device,EPID)获取患者出射剂量影像,并把首次出射EPID影像作为剩余分次治疗的基准值,后续分次实时治疗野结束后快速将其出射EPID影像与对应基准影像进行γ分析比较,以验证治疗计划是否准确执行于患者身上。设计模体实验对治疗部位错误和摆位误差情况进行分析,来评估本方法识别放疗差错的准确性。结果:本方法可有效地识别出IMRT放疗中患者治疗部位错误和非平行于射野角度方向的摆位误差,但对平行于射野角度方向的摆位误差并不敏感,30例鼻咽癌患者临床应用结果中能够直观显示分次治疗间摆位重复性情况。结论:基于EPID实现的一种在体剂量验证方法能够对调强放疗中患者实时剂量的准确性进行评估,在单个治疗野结束后可快速检测出较大治疗错误。  相似文献   
4.

Objective

To determine the association between provider training level and postplacental intrauterine device (IUD) outcomes following insertion instruction by email only.

Study design

We conducted a single-center chart review of demographics, insertion and clinical outcomes within 6 months of delivery for 116 patients who underwent postplacental levonorgestrel 52?mg IUD placement from October 1, 2016, to March 31, 2017.

Results

We confirmed IUD retention, removal or expulsion in 87 of 116 (75.0%) patients by 6 months after delivery. Complete expulsion or removal for malposition occurred in 20 (23.0%) patients and more frequently after vaginal than cesarean delivery (30.2% vs. 4.2%, OR 9.93 [95% CI 1.25–78.96]) and when a postgraduate year (PGY) 1 physician placed the IUD compared to a PGY 2–4 or attending physician (37.5% vs. 14.5%, OR 3.52 [95% CI 1.25–9.94]).

Conclusion

Postplacental levonorgestrel 52?mg IUD expulsion rates are associated with provider training level as well as delivery route, though the individual association of each of these factors is difficult to ascertain given the high degree of collinearity between these two variables in our study.  相似文献   
5.

Objectives

We explored levonorgestrel (LNG) concentrations, bleeding patterns and endometrial thickness in women with epilepsy (WWE) initiating an LNG-intrauterine device (IUD) co-administered with antiepileptic drugs (AEDs).

Study design

This pilot study included 20 WWE ages 18 to 45 years with well-controlled seizures and stable AED regimens initiating a 52-mg LNG-IUD (20 mcg/d initial release). We collected blood and measured endometrial thickness before IUD placement and 21 days, 3 months and 6 months thereafter. Participants recorded bleeding/spotting daily. We measured total LNG (radioimmunoassay), serum hormone binding globulin (SHBG, immunoassay) and calculated the free LNG index. We compared total LNG, free LNG index, SHBG and endometrial thickness over time using a linear mixed-effects model.

Results

Total LNG, free LNG index and SBHG levels remained stable from day 21 throughout. Endometrial thickness decreased from a median of 5.9 mm [interquartile range (IQR) 4.6–7.5] at day 21 to 3.3mm (2.8–4.9) by month 6 (p=0.02). Bleeding and spotting days decreased from a median of 16 (IQR 13–23) in month 1 to 6.5 (IQR 4–8.5) in month 6 regardless of AED regimen.

Conclusion

Like women without epilepsy, WWE initiating the LNG-IUD experience stable total LNG concentrations and decreasing endometrial thickness and bleeding over the first 6 months of use.

Implications

Like women without epilepsy, WWE using antiepileptic drugs can expect a stable LNG concentration and decreasing bleeding during the first 6 months of LNG-IUD use. Our data can be useful for guidance of WWE considering use the LNG-IUD.  相似文献   
6.
7.
ObjectiveTo assess the impact of training on use of inhalational techniques of different inhaler devices in spirometry proved cases of COPD and Bronchial Asthma in a tertiary care centre.MethodsA total of 128 spirometry proved cases of Asthma and COPD were enrolled. They were equally distributed in four groups comprising of 32 patients each according to their inhalation devices namely pMDI, Rotahaler, Accuhaler and Turbohaler. Patients were asked to demonstrate their inhalation technique and errors were noted according to their inhaler specific checklist. Patients were also interviewed regarding their knowledge about inhalation devices. Training about proper inhalation techniques was given to every participant. Rechecking of inhalation technique was again done at the second visit after 2 wks in the similar manner. Correct and incorrect steps of inhalation technique again evaluated by filling the checklist of the individual device to see post training improvement.ResultIn our study, out of total cases more than one third of the patients were >60 yrs of age (41.4%) and most of the patients were males (62.5%). During the interview at first visit, almost 92% patients claimed to know how to use the inhalation device correctly but in reality most of the patients (around 96.1%) had committed at least one mistakes in their inhalation technique among all the inhalation steps. Errors were noted in different steps of inhalation including the essential steps among all the four devices. Statistically significant improvement in inhalation techniques including the essential steps were found among all the four devices after educational intervention and demonstration of sequential steps involved in particular inhaler.ConclusionOur study confirmed a significant increase in the percentage of improvement in inhalation technique after proper demonstration and training about the inhalation devices. Inhalation technique including essential steps of inhalation significantly improved in all the four devices used.  相似文献   
8.
9.

Objective

Phlebolymphedema (chronic venous insufficiency-related lymphedema) is a common and costly condition. Nevertheless, there is a dearth of evidence comparing phlebolymphedema therapeutic interventions. This study sought to examine the medical resource utilization and phlebolymphedema-related cost associated with Flexitouch (FLX; Tactile Medical, Minneapolis, Minn) advanced pneumatic compression devices (APCDs) relative to conservative therapy (CONS) alone, simple pneumatic compression devices (SPCDs), and other APCDs in a representative U.S. population of phlebolymphedema patients.

Methods

This was a longitudinal matched case-control analysis of deidentified private insurance claims. The study used administrative claims data from Blue Health Intelligence for the complete years 2012 through 2016. Patients were continuously enrolled for at least 18 months, diagnosed with phlebolymphedema, and received at least one claim for CONS either alone or in addition to pneumatic compression (SPCDs or APCDs). The main outcomes included direct phlebolymphedema- and sequelae-related medical resource utilization and costs.

Results

After case matching, the study included 86 patients on CONS (87 on FLX), 34 on SPCDs (23 on FLX), and 69 on other APCDs (67 on FLX). Compared with CONS, FLX was associated with 69% lower per patient per year total phlebolymphedema- and sequelae-related costs net of any pneumatic compression device-related costs ($3839 vs $12,253; P = .001). This was driven by 59% fewer mean annual hospitalizations (0.13 vs 0.32; P < .001) corresponding to 82% lower inpatient costs and 55% lower outpatient hospital costs. FLX was also associated with 52% lower outpatient physical therapy and occupational therapy costs and 56% lower other outpatient-related costs. Compared with SPCDs, FLX was associated with 85% lower total costs ($1153 vs $7449; P = .008) driven by 93% lower inpatient costs ($297 vs $4215; P = .002), 84% lower outpatient hospital costs ($368 vs $2347; P = .020), and 85% lower other outpatient-related costs ($353 vs $2313; P = .023). Compared with APCDs, FLX was associated with 53% lower total costs ($3973 vs $8436; P = .032) because of lower outpatient costs and lower rates of cellulitis (22.4% vs 44.9% of patients; P = .02).

Conclusions

This analysis indicates significant benefits attributable to FLX compared with alternative compression therapies that can help reduce the notable economic burden of phlebolymphedema.  相似文献   
10.
Purpose: To describe how central venous access devices (CVADs) are utilized for ambulatory oncology patients and to evaluate the rate of complications. Method: Single institution retrospective study of oncology patients with CVADs who received systemic treatment at the Walker Family Cancer Centre (WFCC) between 1 January and 31 December 2018. Results: A total of 480 CVADS were placed in 305 patients, of which 408 (85%) were peripherally inserted central catheters (PICCs) and 72 (15%) were implanted vascular access devices (PORTs). The incidence of early and late complications was 9% and 24%, respectively. For the entire cohort, the rate of venous thromboembolism (VTE) was 16%, of which 9% were CVAD-related thrombosis (CRTs) and 7% were distant VTE. The CRT rates were similar for PICCs and PORTs (9% vs. 7%). A total of 6% of CVADs were complicated by infection (i.e., localized infections and bacteremia), with a total infection rate of 0.43 and 0.26 per 1000 indwelling days for PICCs and PORTs, respectively. The incidence of central line associated bloodstream infections (CLABSI) was greater for PICCs than PORTs, at a rate of 0.22 compared with 0.08 per 1000 indwelling days, respectively. The premature catheter removal rate was 26% for PICCs and 18% for PORTs. PORTs required more additional hospital visits. Conclusions: PICCs were utilized more frequently than PORTs and had a higher rate of premature removal. The rates of VTE and CRT were similar for both CVAD types. PORTs had a lower rate of infection per 1000 indwelling days. However, the management of PORT related complications required more visits to the hospital and oncology clinic.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号